Trading Halt Active
This ticker is currently halted. Check the Halts tab for details.
Volatility Alert
This ticker is experiencing unusual price movement.
Key Stats
Day Range
$19.23
$20.74
52-Week Range
$12.95
$38.41
14-Day RSI
-
Upcoming Earnings
---
---
Volume
-
Analyst Rating
-
-
-
-
Price Target
-
-
Last Earnings
-
-
About
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.
Valuation
300.82M
Market Cap
-
Forward P/E
-
Trailing P/E
-
Price/Book
-
EPS (TTM)
Financial Snapshot
-
Revenue (TTM)
-
EBITDA
-
Free CF
-
Total Debt
-
Beta
Margins & Dividends
-
Gross Margin
-
Op. Margin
-
Div Rate
-
Div Yield
-
Ex-Div Date
Profile
-
Sector
-
Industry
-
Short % Float
Nearest Expiry:
Loading...
Max Pain:
$0.00
Support (Put Wall)
$0.00
OI: 0
Current Price
$0.00
Resistance (Call Wall)
$0.00
OI: 0
Calls
Loading...
Puts
Loading...
Unusual Whale Flow
Loading anomaly scanner...
Experimental. Executive-branch trades are sourced from a third-party aggregator (open-cabinet.org) that parses OGE filings — not yet independently verified. Most executive-branch filings are bonds; only trades resolved to an equity ticker appear here.